Zika virus genome from the Americas

www.thelancet.com Vol 387 January 16, 2016 227 3 Griffi ths CEM, Reich K, Lebwohl M, et al. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 2015; 386: 541–51. 4 Beurel E, Harrington LE, Jope RS. Infl ammatory T helper 17 cells promote depression-like behavior in mice. Biol Psychiatry 2013; 73: 622–30. 5 Papp KA, Leonardi C, Menter A, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012; 366: 1181–89.

[1]  D. Musso,et al.  Emerging arboviruses in the Pacific , 2014, The Lancet.

[2]  R. Lanciotti,et al.  Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.

[3]  A. L. Mosimann,et al.  First report of autochthonous transmission of Zika virus in Brazil , 2015, Memorias do Instituto Oswaldo Cruz.

[4]  D. Musso,et al.  Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.